A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction

NCT04840914 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Heart Failure With Reduced Ejection Fraction

Interventions

DRUG: LY3461767
DRUG: Placebo

Sponsor

Eli Lilly and Company